$0.38
-0.008[-2.06%]
At close: Apr 24
$0.38
0[0.00%]
After Hours: 7:10PM EDT
Trevena
(NASDAQ:TRVN)Latest News for Trevena Stock (NASDAQ:TRVN)
Trevena Stock (NASDAQ: TRVN)
Categories: All
Friday, April 19, 2024
Thursday, April 18, 2024
Wednesday, April 17, 2024
Tuesday, April 02, 2024
Monday, April 01, 2024
Friday, March 22, 2024
Monday, March 11, 2024
Tuesday, February 27, 2024
- Trevena Granted US Patent 11,912,693 Titled 'Compounds For Modulating S1P1 Activity And Methods Of Using The Same'Benzinga Newsdesk - Feb 27, 2024, 12:43PM
- Trevena Has Been Granted U.S. Patent 11,912,713 Titled "7-membered Aza-Heterocyclic Containing Delta-Opioid Receptor Modulating Compounds, Methods Of Using And Making (For Treating Pain, Migraines, Depression, Parkinsons Disease, And Other Disorders)Benzinga Newsdesk - Feb 27, 2024, 12:33PM
Tuesday, January 16, 2024
Tuesday, January 09, 2024
Wednesday, December 27, 2023
Monday, November 27, 2023
Tuesday, November 14, 2023
- Earnings Scheduled For November 14, 2023Benzinga Insights - Nov 14, 2023, 8:23AM
- Recap: Trevena Q3 EarningsBenzinga Insights - Nov 14, 2023, 7:05AM
- Trevena Q3 EPS $(0.57) Misses $(0.15) Estimate, Sales $180.00K Beat $100.00K Estimate; Cash And Cash Equivalents Of $35M Is Expected To Be Sufficient To Fund The Company's Operating Expenses And Capital Expenditure Requirements Into Q3 2024Benzinga Newsdesk - Nov 14, 2023, 7:04AM
Monday, November 13, 2023
Tuesday, November 07, 2023
Monday, October 16, 2023
Monday, September 11, 2023
Friday, September 08, 2023
Thursday, September 07, 2023
Wednesday, September 06, 2023
- Trevena shares are trading higher after the company reported preliminary TRV045 data from two proof-of-concept studies.Benzinga Newsdesk - Sep 6, 2023, 10:03AM
- Why Is Neurology Focused Trevena Stock Trading Higher Today?Vandana Singh - Sep 6, 2023, 9:23AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Sep 6, 2023, 9:06AM
- Market-Moving News for September 6thBenzinga Newsdesk - Sep 6, 2023, 8:38AM
- Trevena Reports Preliminary TRV045 Data From Two Proof-of-Concept Studies Evaluating S1PR Mechanism Of Action And CNS Target EngagementBenzinga Newsdesk - Sep 6, 2023, 7:22AM
- Trevena Announces Receipt Of $15M Non-Dilutive TrancheBenzinga Newsdesk - Sep 6, 2023, 7:02AM
Wednesday, August 16, 2023
Monday, August 14, 2023
Friday, July 21, 2023
Wednesday, July 19, 2023
Monday, June 26, 2023
Wednesday, May 31, 2023
Wednesday, May 17, 2023
Monday, May 15, 2023
- Trevena Expects To Receive Additional $15M Non-dilutive Tranche From R-Bridge Upon First Commercial Sale Of Olinvyk In ChinaBenzinga Newsdesk - May 15, 2023, 7:10AM
- Trevena Q1 EPS $(0.81) Beats $(0.98) Estimate, Sales $6.00K Down From $20.00K YoYBenzinga Newsdesk - May 15, 2023, 7:02AM
- Earnings Scheduled For May 15, 2023Benzinga Insights - May 15, 2023, 5:32AM
Friday, May 12, 2023
Tuesday, May 09, 2023
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - May 9, 2023, 1:31PM
- Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - May 9, 2023, 1:24PM
- Trevena shares are trading lower on profit taking after the stock rallied yesterday.Benzinga Newsdesk - May 9, 2023, 1:23PM